Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop

Kluetz, PG, Kanapuru, B, Lemery, S et al. (25 more authors) (2018) Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop. Value in Health, 21 (6). pp. 742-747. ISSN 1098-3015

Abstract

Metadata

Authors/Creators:
  • Kluetz, PG
  • Kanapuru, B
  • Lemery, S
  • Johnson, LL
  • Fiero, MH
  • Arscott, K
  • Barbachano, Y
  • Basch, E
  • Campbell, M
  • Cappelleri, JC
  • Cella, D
  • Cleeland, C
  • Coens, C
  • Daniels, S
  • Denlinger, CS
  • Fairclough, DL
  • Hillard, JR
  • Minasian, L
  • Mitchell, SA
  • O'Connor, D
  • Patel, S
  • Rubin, EH
  • Ryden, A
  • Soltys, K
  • Sridhara, R
  • Thanarajasingam, G
  • Velikova, G https://orcid.org/0000-0003-1899-5942
  • Coons, SJ
Copyright, Publisher and Additional Information: © 2018, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. This is an author produced version of a paper published in Value in Health. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: drug safety; oncology; patient-reported outcomes; PRO-CTCAE; tolerability
Dates:
  • Published: June 2018
  • Accepted: 20 September 2017
  • Published (online): 7 November 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP)
Depositing User: Symplectic Publications
Date Deposited: 05 Dec 2017 11:56
Last Modified: 07 Nov 2018 01:39
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.jval.2017.09.009

Downloads

Filename: KLUETZ FIGURE 1.pdf

Description: Figure 1

Licence: CC-BY-NC-ND 4.0

Share / Export

Statistics